Results 141 to 150 of about 28,817 (265)

Evaluation of Myocardial Stiffness in Cardiac Amyloidosis Using Acoustic Radiation Force Impulse and Natural Shear Wave Imaging [PDF]

, 2023
Felix Q. Jin, Vaibhav Kakkad, David Bradway, Melissa LeFevre, Joseph Kisslo, Michel G. Khouri, Gregg E. Trahey   +6 more
openalex   +1 more source

Fulminant cardiac amyloidosis

European Heart Journal - Case Reports, 2021
Carlos Real, Teresa Morales, Ana Viana-Tejedor   +2 more
openaire   +3 more sources

Nuclear imaging and echocardiographic findings in hypertrophic cardiomyopathy with and without ATTR‐CM

ESC Heart Failure, Volume 12, Issue 6, Page 4349-4358, December 2025.
Abstract Aims Patients with transthyretin amyloid cardiomyopathy (ATTR‐CM) often experience delayed diagnosis, which may detrimentally impact clinical outcomes. This study aimed to assess the frequency of use of planar scintigraphy with and without single‐photon emission computed tomography (SPECT) in patients with hypertrophic cardiomyopathy (HCM ...
Pablo Garcia‐Pavia, Francisco Javier Haro del Moral, Francesco Cappelli, Nicolas Piriou, Roberto Barriales‐Villa, Carmen Munteanu, Catherine Bahus, Denis Keohane, Pablo Mallaina, Emmanuel Itti, Thibaud Damy, Perry Elliott   +11 more
wiley   +1 more source

A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant [PDF]

, 2020
Ryohei Ono, Hidehisa Takahashi, Tetta Sato, Tatsuro Yamazaki, Yasuhiko Hori, Kenichi Fukushima   +5 more
openalex   +1 more source

Risk stratification in transthyretin-related cardiac amyloidosis [PDF]

, 2023
Riccardo Scirpa, Edoardo Cittadini, Lorenzo Mazzocchi, Giacomo Tini, Matteo Sclafani, Domitilla Russo, Andrea Imperatrice, Alessandro Tropea, Camillo Autore, Beatrice Musumeci   +9 more
openalex   +1 more source

Impact of early intensive GDMT on LVEF recovery and ICD decision making in de novo HFrEF

ESC Heart Failure, Volume 12, Issue 6, Page 4299-4304, December 2025.
Abstract Aims Implantable cardioverter‐defibrillator (ICD) implantation is recommended in patients with heart failure with reduced ejection fraction (HFrEF) and left ventricular ejection fraction (LVEF) ≤ 35% after 3 months of optimized medical therapy (OMT).
Diogo Rosa Ferreira, Daniel Inácio Cazeiro, Joana Brito, Rafael Santos, Joana Rigueira, Doroteia Silva, Nuno Lousada, Fausto Pinto, Dulce Brito, João Agostinho   +9 more
wiley   +1 more source

Case Report: Challenges in the diagnosis and treatment of cardiac amyloidosis: a case misdiagnosed as dual cardiac amyloidosis. [PDF]

Front Cardiovasc Med
Ma M, Liu L, Liu X, Cai X, Yang W.
europepmc   +1 more source

Two Decades of Cardiac Amyloidosis

, 2021
Oscar Westin, Jawad H. Butt, Finn Gustafsson, Morten Schou, Morten Salomo, Lars Køber, Mathew S. Maurer, Emil Loldrup Fosbøl   +7 more
openalex   +1 more source

Exercise‐induced out‐of‐proportion increase in afterload and impaired right ventricular contractile reserve in HFpEF

ESC Heart Failure, Volume 12, Issue 6, Page 4391-4400, December 2025.
Non‐cardiac dyspnoea (n = 34, NCD) and heart failure with preserved ejection fraction (n = 34, HFpEF) patients were classified according to right heart catheterisation. Cardiovascular magnetic resonance derived right ventricular (RV) haemodynamic indices for afterload (Ea), contractility (Ees) and RV/pulmonary artery coupling (Ea/Ees) were evaluated ...
Jan Sebastian Wolter, Alexander Schulz, Torben Lange, Steffen D. Kriechbaum, Shelby Kutty, Johannes T. Kowallick, Julia M. Treiber, Andreas Rolf, Samuel Sossalla, Gerd Hasenfuß, Andreas Schuster, Sören J. Backhaus   +11 more
wiley   +1 more source

Cardiac Amyloidosis: Tribulations and New Frontiers. [PDF]

J Pers Med
Nguyen DM, Ramazani N, Sodhi G, Tak T.
europepmc   +1 more source